CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Contact Isolation Precautions for Ambulatory Oncology Patients Positive for Antibiotic Resistant Organisms: A Review of Clinical Effectiveness and Guidelines

Last updated: October 6, 2015
Project Number: RC0712-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Summary with Critical Appraisal
Result type: Report

Question

  1. What is the comparative clinical effectiveness of contact isolation precautions versus routine infection prevention practices for ambulatory oncology patients infected or colonized with antibiotic resistant organisms (AROs)?
  2. What are the evidence-based guidelines regarding the use of contact isolation precautions for ambulatory oncology patients infected or colonized with AROs?

Key Message

No relevant literature was identified pertaining to comparative clinical effectiveness of contact isolation precautions versus routine infection prevention practices for ambulatory oncology patients infected or colonized with antibiotic resistant organisms. Similarly, no evidence-based guidelines regarding the use of contact isolation precautions for ambulatory oncology patients infected or colonized with AROs.